Lamivudine 62135-0706-24
Generic: Lamivudine Oral
- Manufacturer
- Chartwell Rx, Llc
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 31, 2014
- Listing Expires
- December 31, 2026
- Application
- ANDA203564
Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 10 mg/mL |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Selected Package
62135-0706-24Selected2 TRAY in 1 BOX (62135-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (62135-706-30)
Other packages for this product(1)
240 mL in 1 BOTTLE, PLASTIC (62135-706-37)